Molecular Landscape of Pelvic Organ Prolapse Provides Insights into Disease Etiology

Pelvic organ prolapse (POP) represents a major health care burden in women, but its underlying pathophysiological mechanisms have not been elucidated. We first used a case-control design to perform an exome chip study in 526 women with POP and 960 control women to identify single nucleotide variants (SNVs) associated with the disease. We then integrated the functional interactions between the POP candidate proteins derived from the exome chip study and other POP candidate molecules into a molecular landscape. We found significant associations between POP and SNVs in 54 genes. The proteins encoded by 26 of these genes fit into the molecular landscape, together with 43 other POP candidate molecules. The POP landscape is located in and around epithelial cells and fibroblasts of the urogenital tract and harbors four interacting biological processes—epithelial-mesenchymal transition, immune response, modulation of the extracellular matrix, and fibroblast function—that are regulated by sex hormones and TGFB1. Our findings were corroborated by enrichment analyses of differential gene expression data from an independent POP cohort. Lastly, based on the landscape and using vaginal fibroblasts from women with POP, we predicted and showed that metformin alters gene expression in these fibroblasts in a beneficial direction. In conclusion, our integrated molecular landscape of POP provides insights into the biological processes underlying the disease and clues towards novel treatments.

[1]  K. Kluivers,et al.  Risk factors for primary pelvic organ prolapse and prolapse recurrence: an updated systematic review and meta-analysis. , 2022, American journal of obstetrics and gynecology.

[2]  G. Gurusubramanian,et al.  Effects of metformin on the uterus of d-galactose-induced aging mice: Histomorphometric, immunohistochemical localization (B-cell lymphoma 2, Bcl2-associated X protein, and active capase3), and oxidative stress study. , 2022, Journal of experimental zoology. Part A, Ecological and integrative physiology.

[3]  M. Hellerstein,et al.  Transcriptome and proteome dynamics of cervical remodeling in the mouse during pregnancy , 2021, Biology of Reproduction.

[4]  M. Shahhoseini,et al.  Metformin attenuates expression of angiogenic and inflammatory genes in human endometriotic stromal cells. , 2021, Experimental cell research.

[5]  M. Carazzolle,et al.  Evidence of macrophage modulation in the mouse pubic symphysis remodeling during the end of first pregnancy and postpartum , 2020, Scientific Reports.

[6]  K. Kluivers,et al.  Extracellular Matrix Stiffness and Composition Regulate the Myofibroblast Differentiation of Vaginal Fibroblasts , 2020, International journal of molecular sciences.

[7]  Hannes P. Eggertsson,et al.  Genome-wide association identifies seven loci for pelvic organ prolapse in Iceland and the UK Biobank , 2020, Communications Biology.

[8]  L. Cannon-Albright,et al.  Risk of Pelvic Organ Prolapse Treatment Based on Extended Family History. , 2020, American journal of obstetrics and gynecology.

[9]  A. Vetuschi,et al.  Immunolocalization of Advanced Glycation End Products, Mitogen Activated Protein Kinases, and Transforming Growth Factor-β/Smads in Pelvic Organ Prolapse , 2018, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[10]  Kevin Chagin,et al.  Predicting risk of pelvic floor disorders 12 and 20 years after delivery , 2017, American journal of obstetrics and gynecology.

[11]  L. Salnikova,et al.  Expression changes in pelvic organ prolapse: a systematic review and in silico study , 2017, Scientific Reports.

[12]  T. Gasser,et al.  Integrated molecular landscape of Parkinson’s disease , 2017, npj Parkinson's Disease.

[13]  L. Kiemeney,et al.  Cohort Profile Cohort Profile : The Nijmegen Biomedical Study ( NBS ) , 2017 .

[14]  X. Fang,et al.  Metformin is a novel suppressor for transforming growth factor (TGF)-β1 , 2016, Scientific Reports.

[15]  T. Smit,et al.  Vaginal Fibroblastic Cells from Women with Pelvic Organ Prolapse Produce Matrices with Increased Stiffness and Collagen Content , 2016, Scientific Reports.

[16]  B. Franke,et al.  Prioritization and burden analysis of rare variants in 208 candidate genes suggest they do not play a major role in CAKUT. , 2016, Kidney international.

[17]  Hui Zhang,et al.  Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells , 2016, Oncotarget.

[18]  Yong He,et al.  Metformin attenuates gefitinib-induced exacerbation of pulmonary fibrosis by inhibition of TGF-β signaling pathway , 2015, Oncotarget.

[19]  C. Liu,et al.  Oxidative damage to human parametrial ligament fibroblasts induced by mechanical stress. , 2015, Molecular medicine reports.

[20]  J. Jung,et al.  Clinicopathological significance of N-cadherin and VEGF in advanced gastric cancer brain metastasis and the effects of metformin in preclinical models. , 2015, Oncology reports.

[21]  K. Kluivers,et al.  Risk factors for pelvic organ prolapse and its recurrence: a systematic review , 2015, International Urogynecology Journal.

[22]  M. Horinaka,et al.  Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells , 2015, PloS one.

[23]  Jianhua Shi,et al.  Activation of AMPK by metformin inhibits TGF-β-induced collagen production in mouse renal fibroblasts. , 2015, Life sciences.

[24]  Phillip R. Bennett,et al.  Systematic review and metaanalysis of genetic association studies of urinary symptoms and prolapse in women , 2015, American journal of obstetrics and gynecology.

[25]  Raphael Gottardo,et al.  Orchestrating high-throughput genomic analysis with Bioconductor , 2015, Nature Methods.

[26]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[27]  T. Baer,et al.  Proliferative behavior of vaginal fibroblasts from women with pelvic organ prolapse. , 2014, European journal of obstetrics, gynecology, and reproductive biology.

[28]  J. Schaffer,et al.  Effects of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial. , 2014, The Journal of clinical endocrinology and metabolism.

[29]  Jennifer M Wu,et al.  Lifetime Risk of Stress Urinary Incontinence or Pelvic Organ Prolapse Surgery , 2014, Obstetrics and gynecology.

[30]  S. Ye,et al.  Metformin inhibits nuclear factor‐&kgr;B activation and inflammatory cytokines expression induced by high glucose via adenosine monophosphate‐activated protein kinase activation in rat glomerular mesangial cells in vitro , 2014, Chinese medical journal.

[31]  J. Shendure,et al.  A general framework for estimating the relative pathogenicity of human genetic variants , 2014, Nature Genetics.

[32]  P. Parrino,et al.  Elevation of miR-221 and -222 in the internal mammary arteries of diabetic subjects and normalization with metformin , 2013, Molecular and Cellular Endocrinology.

[33]  B. Franke,et al.  AKAPs integrate genetic findings for autism spectrum disorders , 2013, Translational Psychiatry.

[34]  T. Smit,et al.  Fibroblasts from women with pelvic organ prolapse show differential mechanoresponses depending on surface substrates , 2013, International Urogynecology Journal.

[35]  K. Korach,et al.  The absence of ER-β results in altered gene expression in ovarian granulosa cells isolated from in vivo preovulatory follicles. , 2013, Endocrinology.

[36]  N. Chung,et al.  Involvement of oxidative stress and mitochondrial apoptosis in the pathogenesis of pelvic organ prolapse. , 2013, The Journal of urology.

[37]  Patrick F. Sullivan,et al.  zCall: a rare variant caller for array-based genotyping: Genetics and population analysis , 2012, Bioinform..

[38]  Ewout J. N. Groen,et al.  Mapping of Gene Expression Reveals CYP27A1 as a Susceptibility Gene for Sporadic ALS , 2012, PloS one.

[39]  K. Kluivers,et al.  A systematic review of clinical studies on hereditary factors in pelvic organ prolapse , 2012, International Urogynecology Journal.

[40]  L. Cannon-Albright,et al.  Identification of Six Loci Associated With Pelvic Organ Prolapse Using Genome-Wide Association Analysis , 2011, Obstetrics and gynecology.

[41]  Fionn Murtagh,et al.  Ward’s Hierarchical Agglomerative Clustering Method: Which Algorithms Implement Ward’s Criterion? , 2011, Journal of Classification.

[42]  Jin-Ying Zhang,et al.  Beneficial effects of metformin on primary cardiomyocytes via activation of adenosine monophosphate-activated protein kinase. , 2011, Chinese medical journal.

[43]  L. Hong,et al.  Expression of transforming growth factor-beta 1 and connective tissue growth factor in women with pelvic organ prolapse. , 2011, Saudi medical journal.

[44]  B. Franke,et al.  Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder. , 2011, The American journal of psychiatry.

[45]  B. Howard,et al.  Risk Factors for Prolapse Development in White, Black, and Hispanic Women , 2011, Female pelvic medicine & reconstructive surgery.

[46]  B. Martín-Castillo,et al.  Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis , 2010, Cell cycle.

[47]  S. Abramowitch,et al.  Repetitive Mechanical Stretch Increases Extracellular Collagenase Activity in Vaginal Fibroblasts , 2010, Female pelvic medicine & reconstructive surgery.

[48]  Yi Zhu,et al.  Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway. , 2010, Cardiovascular research.

[49]  J. Mauskopf,et al.  Rate, type, and cost of pelvic organ prolapse surgery in Germany, France, and England. , 2009, European journal of obstetrics, gynecology, and reproductive biology.

[50]  M. Eijkemans,et al.  The prevalence of pelvic organ prolapse symptoms and signs and their relation with bladder and bowel disorders in a general female population , 2009, International Urogynecology Journal.

[51]  O. Nyrén,et al.  Nonobstetric Risk Factors for Symptomatic Pelvic Organ Prolapse , 2009, Obstetrics and gynecology.

[52]  P. Lichtenstein,et al.  Genetic influence on stress urinary incontinence and pelvic organ prolapse. , 2008, European urology.

[53]  Tetsuo Yamada,et al.  The identification and structural characterization of C7orf24 as gamma-glutamyl cyclotransferase. An essential enzyme in the gamma-glutamyl cycle. , 2008, The Journal of biological chemistry.

[54]  G. Buchsbaum,et al.  Incontinence and pelvic organ prolapse in parous/nulliparous pairs of identical twins , 2008, Neurourology and urodynamics.

[55]  B. Chung,et al.  Quantitative determination of progesterones and corticosteroids in human urine using gas chromatography/mass spectrometry: application to pelvic organ prolapse patients. , 2008, Rapid communications in mass spectrometry : RCM.

[56]  L. D. White,et al.  Identification of murine uterine genes regulated in a ligand-dependent manner by the progesterone receptor. , 2005, Endocrinology.

[57]  A. O'Boyle,et al.  Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects. , 2005, American journal of obstetrics and gynecology.

[58]  K. Nose,et al.  Invasive Potential Induced under Long-Term Oxidative Stress in Mammary Epithelial Cells , 2004, Cancer Research.

[59]  C. Bradley,et al.  Pelvic Organ Prolapse in Older Women: Prevalence and Risk Factors , 2004, Obstetrics and gynecology.

[60]  A. Visvikis,et al.  The changing faces of glutathione, a cellular protagonist. , 2003, Biochemical pharmacology.

[61]  Pamela A. Moalli,et al.  Risk Factors Associated With Pelvic Floor Disorders in Women Undergoing Surgical Repair , 2003, Obstetrics and gynecology.

[62]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[63]  L. Brubaker,et al.  The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. , 1996, American journal of obstetrics and gynecology.

[64]  R. Grantham Amino Acid Difference Formula to Help Explain Protein Evolution , 1974, Science.

[65]  F. E. Grubbs Procedures for Detecting Outlying Observations in Samples , 1969 .

[66]  A. Heintz,et al.  Measuring health‐related quality of life in women with urogenital dysfunction: The urogenital distress inventory and incontinence impact questionnaire revisited , 2003, Neurourology and urodynamics.